American Century Companies Inc. reduced its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 20.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 28,069 shares of the business services provider's stock after selling 7,218 shares during the period. American Century Companies Inc. owned 0.06% of Exponent worth $2,501,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the business. Venturi Wealth Management LLC raised its stake in shares of Exponent by 4.6% during the 4th quarter. Venturi Wealth Management LLC now owns 2,531 shares of the business services provider's stock valued at $226,000 after purchasing an additional 111 shares during the period. Heritage Family Offices LLP lifted its holdings in shares of Exponent by 3.8% in the fourth quarter. Heritage Family Offices LLP now owns 3,123 shares of the business services provider's stock worth $278,000 after buying an additional 114 shares in the last quarter. Arizona State Retirement System boosted its position in shares of Exponent by 0.9% in the fourth quarter. Arizona State Retirement System now owns 14,723 shares of the business services provider's stock valued at $1,312,000 after acquiring an additional 133 shares during the period. Private Trust Co. NA grew its stake in Exponent by 129.8% during the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after acquiring an additional 157 shares in the last quarter. Finally, Pacer Advisors Inc. increased its holdings in Exponent by 2.4% during the 4th quarter. Pacer Advisors Inc. now owns 7,574 shares of the business services provider's stock worth $675,000 after acquiring an additional 180 shares during the period. 92.37% of the stock is owned by hedge funds and other institutional investors.
Exponent Trading Up 1.7 %
Shares of EXPO traded up $1.32 during mid-day trading on Friday, reaching $80.32. 307,072 shares of the stock traded hands, compared to its average volume of 242,311. The company has a market cap of $4.08 billion, a price-to-earnings ratio of 37.89 and a beta of 0.84. Exponent, Inc. has a 1 year low of $73.83 and a 1 year high of $115.75. The firm has a fifty day moving average price of $83.53 and a 200 day moving average price of $93.26.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period last year, the company posted $0.41 EPS. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.
Insider Buying and Selling at Exponent
In related news, VP Richard Reiss sold 1,736 shares of the business's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. The trade was a 49.10 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.10% of the stock is currently owned by company insiders.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.